Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > we stay

<< Previous

Bullboard Posts

Next >>

Comment by Solid1on May 19, 2024 6:09am

107 Views

Post# 36047724

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:we stay

You forget that Medipharm Labs has two applications pending with the FDA and has little to do with the recreational market. The medical market for cannabinoids in the US is estimated to be 100 billion over the next few years and there are very few companies that meet the FDA/DEA requirements.

Why would Labs' market share be very small if they are currently the only ones in North America that meet FDA and DEA requirements? And even if they only have 1% market share, that's still 1 billion in sales...

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages